lamin-B2 deaminated 1 (human)

A lamin-B2 (human) that has been deaminated on the residue at the position equivalent to Asn-490 of the amino acid sequence represented by UniProtKB:Q03252. UniProtKB:Q03252, Asn-490, MOD:00684.


neurexin-1-alpha isoform a3 (mouse)

A neurexin-1-alpha isoform a3 that is encoded in the genome of mouse.


name: dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 1 (mouse)

description: A dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform 1 that is encoded in the genome of mouse.


name: PDE11_MOUSE Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (sprot)

description: A dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A that is encoded in the genome of mouse.


name: night blindness-skeletal anomalies-dysmorphism syndrome

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: This syndrome is characterized by night blindness, skeletal abnormalities (sloping shoulders, joint hyperextensibility, minor radiological anomalies) and characteristic facies (periorbital anomalies, malar flatness, retrognathia).


name: GAS4_SCHPO 1,3-beta-glucanosyltransferase gas4 (sprot)

description: A protein that is a translation product of the gas4 gene in Schizosaccharomyces pombe 972h-.


name: HRPA_ECOLI ATP-dependent RNA helicase HrpA (sprot)

description: An ATP-dependent RNA helicase HrpA that is encoded in the genome of Escherichia coli K-12.


ATP-dependent RNA helicase HrpA

A protein that is a translation product of the Escherichia coli K-12 hrpA gene or a 1:1 ortholog thereof.


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the phosphatidyl acyl groups are both oleoyl.


A polysaccharide derivative composed of a backbone of linear octasaccharide derivative repeating units consisting of beta-QuiN4Fm-(1->4)-alpha-GalNAcAN-(1->4)-alpha-GalNAcAN-(1->3)-beta-QuiNAc-(1->2)-beta-QuiN4Fm-(1->4)-alpha-GalNAcAN-(1->4)-alpha-GalNAcAN-(1->3)-beta-QuiNAc connected by beta-(1->2) linkages.


name: glutaminase liver isoform, mitochondrial isoform 1 (rat)

description: A glutaminase liver isoform, mitochondrial isoform 1 that is encoded in the genome of rat.


name: GLSL_RAT Glutaminase liver isoform, mitochondrial (sprot)

description: A glutaminase liver isoform, mitochondrial that is encoded in the genome of rat.


name: glutaminase liver isoform, mitochondrial isoform r2 (rat)

description: A glutaminase liver isoform, mitochondrial (rat) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P28492-2.


name: fatty acid-binding protein 5 isoform 1 (human)

description: A fatty acid-binding protein 5 isoform 1 that is encoded in the genome of human.


name: fatty acid-binding protein 5 deaminated 1 (human)

description: A fatty acid-binding protein 5 (human) that has been deaminated on the residue at the position equivalent to Gln-6 of the amino acid sequence represented by UniProtKB:Q01469. UniProtKB:Q01469, Gln-6, MOD:00685.


name: fatty acid-binding protein 5, initiator methionine removed form (human)

description: A fatty acid-binding protein 5 (human) that has had the initiator methionine removed. UniProtKB:Q01469, 2-135.


rodent arylamine N-acetyltransferase 1

A protein that is a translation product of the mouse Nat1 gene or a 1:1 ortholog thereof in rodents.


name: ARY1_MOUSE Arylamine N-acetyltransferase 1 (sprot)

description: A rodent arylamine N-acetyltransferase 1 that is encoded in the genome of mouse.


calpain-3 isoform Short (mouse)

A calpain-3 isoform 2 that is encoded in the genome of mouse.


pancreatic agenesis

description: Partial agenesis of the pancreas is characterized by the congenital absence of a critical mass of pancreatic tissue.


pancreatic agenesis 2

description: Any pancreatic agenesis in which the cause of the disease is a mutation in the PTF1A gene.


pancreatic agenesis 1

description: Any pancreatic agenesis in which the cause of the disease is a mutation in the PDX1 gene.


name: zinc finger protein 641 isoform h2 (human)

description: A zinc finger protein 641 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96N77-2.


name: MIA40_DANRE Mitochondrial intermembrane space import and assembly protein 40 (sprot)

description: A mitochondrial intermembrane space import and assembly protein 40 that is encoded in the genome of zebrafish.


name: polypeptide N-acetylgalactosaminyltransferase 2 isoform h1 (human)

description: A polypeptide N-acetylgalactosaminyltransferase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q10471-1.


name: GALT2_HUMAN Polypeptide N-acetylgalactosaminyltransferase 2 (sprot)

description: A polypeptide N-acetylgalactosaminyltransferase 2 that is encoded in the genome of human.


name: polypeptide N-acetylgalactosaminyltransferase 2 O-glycosylated 1 (human)

description: A polypeptide N-acetylgalactosaminyltransferase 2 (human) that has been O-glycosylated at the residue equivalent to Thr-368 of the amino acid sequence represented by UniProtKB:Q10471-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:Q10471-1, Thr-368, MOD:00005~GNO:G43417UB.


name: polypeptide N-acetylgalactosaminyltransferase 2 isoform h2 (human)

description: A polypeptide N-acetylgalactosaminyltransferase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q10471-2.


name: M3K2_MOUSE Mitogen-activated protein kinase kinase kinase 2 (sprot)

description: A mitogen-activated protein kinase kinase kinase 2 that is encoded in the genome of mouse.


name: synaptophysin-like protein 2 isoform h1 (human)

description: A synaptophysin-like protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5VXT5-1.


name: probable aminotransferase TAT1 isoform 1 (Arabidopsis thaliana)

description: A probable aminotransferase TAT1 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q67Y55-1.


name: SYGA_ECOLI Glycine--tRNA ligase alpha subunit (sprot)

description: A glycine--tRNA ligase alpha subunit that is encoded in the genome of Escherichia coli K-12.


glycine--tRNA ligase alpha subunit

A protein that is a translation product of the Escherichia coli K-12 glyQ gene or a 1:1 ortholog thereof.


name: SYGA_BACSU Glycine--tRNA ligase alpha subunit (sprot)

description: A glycine--tRNA ligase alpha subunit that is encoded in the genome of Bacillus subtilis subsp. subtilis str. 168.


name: Locally Advanced Unresectable Gastric Adenocarcinoma

description: A gastric adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


Metastatic Unresectable Carcinoma

description: A carcinoma that has spread from its original site of growth to another anatomic site and is not amenable to surgical resection.


name: Metastatic Unresectable Basal Cell Carcinoma

description: A basal cell carcinoma that has spread from its original site of growth to another anatomic site and is not amenable to surgical resection.


name: Locally Advanced Unresectable Esophageal Adenocarcinoma

description: Esophageal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Digestive System Adenocarcinoma

description: Digestive system adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Gastroesophageal Junction Adenocarcinoma

description: Gastroesophageal junction adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Pancreatic Adenocarcinoma

description: A pancreatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Metastatic Unresectable Gastric Adenocarcinoma

description: A gastric adenocarcinoma that has spread from its original site of growth to another anatomic site and is not amenable to surgical resection.


name: Locally Advanced Unresectable Triple-Negative Breast Carcinoma

description: Triple-negative breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Colon Adenocarcinoma

description: A colon adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Basal Cell Carcinoma

description: A basal cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


Locally Advanced Unresectable Carcinoma

description: A carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Prostate Adenocarcinoma

description: A prostatic adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Breast Carcinoma

description: A breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Unresectable Castration-Resistant Prostate Carcinoma

description: Castration-resistant prostate carcinoma that is not amenable to surgical resection.


name: Locally Advanced Unresectable Renal Cell Carcinoma

description: A renal cell carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Colorectal Adenocarcinoma

description: A colorectal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma

description: A pancreatic ductal adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable HER2-Negative Breast Carcinoma

description: A HER2-negative breast adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Cervical Adenocarcinoma

description: A cervical adenocarcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Lung Non-Small Cell Squamous Carcinoma

description: A non-small cell squamous carcinoma of the lung that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable HER2-Positive Breast Carcinoma

description: HER2-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Fallopian Tube Carcinoma

description: Fallopian tube carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Hormone Receptor-Positive Breast Carcinoma

description: Hormone receptor-positive breast carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Prostate Carcinoma

description: A prostatic carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


name: Locally Advanced Unresectable Cervical Carcinoma

description: A cervical carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes and is not amenable to surgical resection.


Stage IA Uterine Sarcoma AJCC v7

description: Stage IA includes: T1a, N0, M0.  T1a: For leiomyosarcoma and endometrial stromal sarcoma: tumor 5 cm or less in greatest dimension.  For adenosarcoma: tumor limited to endometrium/endocervix.  N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)


cullin-2 isoform b (worm)

A cullin-2 (worm) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q17390-2.


name: negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis

category: biolink:BiologicalProcess biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac right atrium morphogenesis.


name: negative regulation of planar cell polarity pathway involved in heart morphogenesis

description: Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in heart morphogenesis.


name: negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis

description: Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in outflow tract morphogenesis.


name: negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis

description: Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis.


name: negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis

description: Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in ventricular septum morphogenesis.


name: negative regulation of planar cell polarity pathway involved in pericardium morphogenesis

description: Any process that stops, prevents, or reduces the frequency, rate or extent of planar cell polarity pathway involved in pericardium morphogenesis.


name: transcription factor 7-like 2 sequence variant A397W (human)

description: A transcription factor 7-like 2 (human) that has a Trp residue at the position equivalent to Ala-397 of the amino acid sequence represented by UniProtKB:Q9NQB0-1. Example: UniProtKB:Q9NQB0-1, Ala-397, CHEBI:29954.


name: nephrosis-deafness-urinary tract-digital malformations syndrome

description: Nephrosis-deafness-urinary tract-digital malformations syndrome is characterized by anomalies of the urinary tract, thumbs and big toes, deafness and nephrosis. It has been described in five brothers. The mode of transmission has not been clearly established but seems to be either autosomal recessive or X-linked dominant.


hexokinase-2 isoform 1 (mouse)

A hexokinase-2 isoform 1 that is encoded in the genome of mouse.


P2Y5 nucleotide receptor binding

category: biolink:MolecularActivity biolink:Occurrent biolink:OntologyClass biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: Binding to a P2Y5 nucleotide receptor.


RRP5_MOUSE Protein RRP5 homolog (sprot)

A protein RRP5 that is encoded in the genome of mouse.


name: zinc finger CCHC domain-containing protein 9 methylated 1 (human)

description: A zinc finger CCHC domain-containing protein 9 (human) that has been methylated on the residue at the position equivalent to Cys-186 of the amino acid sequence represented by UniProtKB:Q8N567. UniProtKB:Q8N567, Cys-186, MOD:00660.


name: protein ALTERED SEED GERMINATION 2 isoform 1 (Arabidopsis thaliana)

description: A protein ALTERED SEED GERMINATION 2 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q94BQ3-1.


tonsil neoplasm

description: A neoplasm (disease) that involves the tonsil.


benign neoplasm of tonsil

description: A benign neoplasm that involves the tonsil.


tonsillar lipoma

description: A benign adipose tissue neoplasm of the tonsils.


ochratoxin C

A phenylalanine derivative that is the ethyl ester of ochratoxin A.


5-methylcytidine 5'-monophosphate

A pyrimidine ribonucleoside 5'-monophosphate having 5-methylcytosine as the nucleobase.


SEC14-like protein 2 isoform 1

A SEC14-like protein 2 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O76054-1 or a 1:1 ortholog thereof.


SEC14-like protein 2 isoform 1 (mouse)

A SEC14-like protein 2 isoform 1 that is encoded in the genome of mouse.


name: homeobox protein MIXL1 isoform h2 (human)

description: A homeobox protein MIXL1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H2W2-2.


name: NAA15_MOUSE N-alpha-acetyltransferase 15, NatA auxiliary subunit (sprot)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit that is encoded in the genome of mouse.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit

description: A protein that is a translation product of the human NAA15 gene or a 1:1 ortholog thereof.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit methylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been methylated on the residue at the position equivalent to Cys-214 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Cys-214, MOD:00660.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit hydroxylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been hydroxylated on the residue at the position equivalent to Trp-258 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Trp-258, MOD:01622.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform h2 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BXJ9-4.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit cysteinylated 2 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been cysteinylated on the residue at the position equivalent to Cys-508 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Cys-508, MOD:00765.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit isoform h1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BXJ9-1.


name: NAA15_HUMAN N-alpha-acetyltransferase 15, NatA auxiliary subunit (sprot)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit that is encoded in the genome of human.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit phosphorylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been phosphorylated on the residue at the position equivalent to Tyr-66 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Tyr-66, MOD:00048.


name: N-alpha-acetyltransferase 15, NatA auxiliary subunit cysteinylated 1 (human)

description: An N-alpha-acetyltransferase 15, NatA auxiliary subunit (human) that has been cysteinylated on the residue at the position equivalent to Cys-214 of the amino acid sequence represented by UniProtKB:Q9BXJ9-1. Example: UniProtKB:Q9BXJ9-1, Cys-214, MOD:00765.


RuvB-like 1 methylated 1 (human)

A RuvB-like 1 (human) that has been methylated on the residue at the position equivalent to Cys-49 of the amino acid sequence represented by UniProtKB:Q9Y265-1. Example: UniProtKB:Q9Y265-1, Cys-49, MOD:00660.


Q9SHG8_ARATH At1g17100 (trembl)

A heme-binding protein 2 that is encoded in the genome of Arabidopsis thaliana.


name: ubiquitin conjugation factor E4 A methylated 1 (human)

description: A ubiquitin conjugation factor E4 A (human) that has been methylated on the residue at the position equivalent to Cys-490 of the amino acid sequence represented by UniProtKB:Q14139-1. Example: UniProtKB:Q14139-1, Cys-490, MOD:00660.


name: lysophosphatidic acid receptor 6 isoform 1 (mouse)

description: An oleoyl-L-alpha-lysophosphatidic acid receptor isoform 1 that is encoded in the genome of mouse.


name: SCRK6_ARATH Probable fructokinase-6, chloroplastic (sprot)

description: A protein that is a translation product of the At1g66430 gene in Arabidopsis thaliana.


name: adhesion G protein-coupled receptor B3 isoform 1 (mouse)

description: An adhesion G protein-coupled receptor B3 isoform 1 that is encoded in the genome of mouse.


Volar Melanoma

description: A melanoma that arises from the palmar surface of hands and plantar surface of feet.


name: calcineurin B homologous protein 2 isoform 1 (rat)

description: A calcineurin B homologous protein 2 isoform 1 that is encoded in the genome of rat.


2-isothiocyanatoethyl phosphate

A monoalkyl phosphate that is ethyl phosphate in which one of the methyl hydrogens has been replaced by an isothiocyanato group.


name: PDLI7_DANRE PDZ and LIM domain protein 7 (sprot)

description: A protein that is a translation product of the pdlim7 gene in zebrafish.


name: AAR3_ARATH Defective in cullin neddylation protein AAR3 (sprot)

description: A protein that is a translation product of the AAR3 gene in Arabidopsis thaliana.


formamide biosynthetic process

description: The chemical reactions and pathways resulting in the formation of formamide, the simplest amide, HCONH2, derived from formic acid.


name: anaphase-promoting complex subunit 2 isoform h1 (human)

description: An anaphase-promoting complex subunit 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UJX6-1.


name: F-box only protein 10 isoform h1 (human)

description: An F-box only protein 10 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UK96-1.


NAI2_ARATH TSA1-like protein (sprot)

A protein that is a translation product of the NAI2 gene in Arabidopsis thaliana.


name: TSA1-like protein isoform 2 (Arabidopsis thaliana)

description: A TSA1-like protein (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9LSB4-2.


name: TSA1-like protein isoform 1 (Arabidopsis thaliana)

description: A TSA1-like protein (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9LSB4-1.


name: Q19643_CAEEL PCI domain-containing protein (trembl)

description: A germinal-center associated nuclear protein that is encoded in the genome of worm.


name: D-tagatose 6-phosphate metabolic process

description: The chemical reactions and pathways involving a D-tagatose 6-phosphate.


name: Rab3 GTPase-activating protein non-catalytic subunit isoform m1 (mouse)

description: A Rab3 GTPase-activating protein non-catalytic subunit (mouse) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8BMG7-1.


A branched amino oligosaccharide that is a dodecasaccharide derivative consisting of a beta-D-GlcNAc residue at the reducing end with a beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[beta-D-GalNAc-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)]-[beta-D-Xyl-(1->2)]-beta-D-Man-(1->4)-beta-D-GlcNAc moiety attached via a beta-(1->4) linkage and with two alpha-L-fucosyl residues attached via (1->3) and (1->6) linkages.


name: growth factor receptor-bound protein 7 isoform 1 (rat)

description: A growth factor receptor-bound protein 7 isoform 1 that is encoded in the genome of rat.


trivalent inorganic cation

An atom or small molecule with a positive charge that does not contain carbon in covalent linkage, with a valency of three.


A cobalt coordination entity consisting of six amino groups bound to a central cobalt atom.


An aluminium cation that has a charge of +3.


An iridium coordination entity consisting of six amino groups bound to a central iridium atom.


A nickel cation in which the nickel carries a triple positive charge.


An alicyclic compound consisting of cyclohexane carrying methyl, methylidene and isopropenyl groups at positions 1-, 2- and 4 respectively.


PNC1_SCHPO Nicotinamidase (sprot)

A nicotinamidase that is encoded in the genome of Schizosaccharomyces pombe 972h-.


nicotinamidase

A protein that is a translation product of the Escherichia coli K-12 pncA gene or a 1:1 ortholog thereof.


PNCA_ECOLI Nicotinamidase (sprot)

A nicotinamidase that is encoded in the genome of Escherichia coli K-12.


PNC1_YEAST Nicotinamidase (sprot)

A nicotinamidase that is encoded in the genome of yeast.


Eccrine angiomatous hamartoma

description: A rare, congenital skin lesion consisting of a proliferation of eccrine glands with a vascular stroma. It presents as a flesh-colored, hyperhidrotic, painful papule or plaque appearing at birth or during childhood.


name: RPE_SCHPO Ribulose-phosphate 3-epimerase (sprot)

description: A protein that is a translation product of the SPAC31G5.05c gene in Schizosaccharomyces pombe 972h-.


name: peptidyl-(Z)-dehydrobutyrine biosynthetic process from peptidyl-threonine

description: The formation of (Z)-dehydrobutyrine by the dehydration of peptidyl-threonine.


name: UBC7_YEAST Ubiquitin-conjugating enzyme E2 7 (sprot)

description: A ubiquitin-conjugating enzyme E2 G2 that is encoded in the genome of yeast.


ubiquitin-conjugating enzyme E2 G2

A protein that is a translation product of the human UBE2G2 gene or a 1:1 ortholog thereof.


name: ubiquitin-conjugating enzyme E2 G2 isoform h2 (human)

description: A ubiquitin-conjugating enzyme E2 G2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P60604-2.


name: UB2G2_MOUSE Ubiquitin-conjugating enzyme E2 G2 (sprot)

description: A ubiquitin-conjugating enzyme E2 G2 that is encoded in the genome of mouse.


name: UBC7_SCHPO Ubiquitin-conjugating enzyme E2-18 kDa (sprot)

description: A ubiquitin-conjugating enzyme E2 G2 that is encoded in the genome of Schizosaccharomyces pombe 972h-.


name: ubiquitin-conjugating enzyme E2 G2 isoform 1

description: A ubiquitin-conjugating enzyme E2 G2 that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P60604-1 or a 1:1 ortholog thereof.


name: UB2G2_HUMAN Ubiquitin-conjugating enzyme E2 G2 (sprot)

description: A ubiquitin-conjugating enzyme E2 G2 that is encoded in the genome of human.


name: ubiquitin-conjugating enzyme E2 G2 isoform 1 (human)

description: A ubiquitin-conjugating enzyme E2 G2 isoform 1 that is encoded in the genome of human.


name: ubiquitin-conjugating enzyme E2 G2 isoform 1 (mouse)

description: A ubiquitin-conjugating enzyme E2 G2 isoform 1 that is encoded in the genome of mouse.


name: ZOP1_ARATH Zinc finger protein ZOP1 (sprot)

description: A protein that is a translation product of the ZOP1 gene in Arabidopsis thaliana.


name: zinc finger protein ZOP1 isoform 1 (Arabidopsis thaliana)

description: A zinc finger protein ZOP1 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7XA66-1.


name: popeye domain-containing protein 3 isoform 1 (chicken)

description: A popeye domain-containing protein 3 (chicken) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9DG25-1.


name: POPD3_CHICK Popeye domain-containing protein 3 (sprot)

description: A popeye domain-containing protein 3 that is encoded in the genome of chicken.


name: popeye domain-containing protein 3 isoform 2 (chicken)

description: A popeye domain-containing protein 3 (chicken) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9DG25-2.


plantar fibromatosis

description: A superficial fibromatosis arising from soft tissue of the plantar regions. It is characterized by the presence of spindle-shaped fibroblasts, hypercellularity, and an infiltrative growth pattern.


isonocardicin C dizwitterion

An alpha-amino acid zwitterion resulting from a transfer of two protons from the carboxy groups to the amino groups of isonocardicin C; major species at pH 7.3.


acene aldehyde

Acenes containing aldehyde groups.


acene dialdehyde

Acenes containing two aldehyde groups.


Acenes containing two aldehyde groups at the 9 and 10 positions.


Acenes containing two aldehyde groups at the 2 and 3 positions.


An amino tetrasaccharide that consists of 4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-2-Me-alpha-D-Man residue at the non-reducing end coupled to three 4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-2-Me-alpha-D-Man in a linear sequence, connected by (11->2)-linkages.


name: breast cancer type 2 susceptibility protein sequence variant K178* (human)

description: A breast cancer type 2 susceptibility protein (human) that has has been truncated after the position equivalent to Pro-177 of the amino acid sequence represented by UniProtKB:P51587. UniProtKB:P51587, 1-177.


name: MPPB_RAT Mitochondrial-processing peptidase subunit beta (sprot)

description: A mitochondrial-processing peptidase subunit beta that is encoded in the genome of rat.


name: mitochondrial-processing peptidase subunit beta isoform 1 (rat)

description: A mitochondrial-processing peptidase subunit beta isoform 1 that is encoded in the genome of rat.


name: coiled-coil domain-containing protein 7 isoform h2 (human)

description: A coiled-coil domain-containing protein 7 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q96M83-2.


cyclin-H isoform 1 (rat)

A cyclin-H isoform 1 that is encoded in the genome of rat.


Kahrizi syndrome

description: An autosomal recessive disease that is characterized by mental retardation, cataracts, coloboma, kyphosis, and coarse facial features and has material basis in mutation in the SRD5A3 gene.


An octene that is octane containing one double bond at position 2.


A 2-octene in which the double bond adopts a trans-configuration.


A 2-octene in which the double bond adopts a cis-configuration.


ESTRAMUSTINE PHOSPHATE SODIUM

An organic sodium salt which is the disodium salt of estramustine phosphate.


name: heterogeneous nuclear ribonucleoprotein U, initiator methionine removed form (human)

description: A heterogeneous nuclear ribonucleoprotein U (human) that has had the initiator methionine removed. UniProtKB:Q00839, 2-825.


name: DNA-repair protein XRCC1 isoform 1 (Arabidopsis thaliana)

description: A DNA-repair protein XRCC1 (Arabidopsis thaliana) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q24JK4-1.


name: MBF1_SCHPO Multiprotein-bridging factor 1 (sprot)

description: An endothelial differentiation-related factor 1 that is encoded in the genome of Schizosaccharomyces pombe 972h-.


name: cysteine-rich secretory protein LCCL domain-containing 1 isoform 1 (mouse)

description: A cysteine-rich secretory protein LCCL domain-containing 1 isoform 1 that is encoded in the genome of mouse.


regulation of chemokine production

description: Any process that modulates the frequency, rate, or extent of chemokine production.


name: regulation of cellular metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances.


name: regulation of nucleotide biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nucleotides.


name: regulation of nonadec-1-ene metabolic process

description: Any process that modulates the frequency, rate or extent of nonadec-1-ene metabolic process.


name: positive regulation of cellular biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells.


regulation of reticulophagy

description: Any process that modulates the frequency, rate or extent of reticulophagy.


name: regulation of antifungal peptide secretion

description: Any process that modulates the frequency, rate, or extent of antifungal peptide secretion.


name: regulation of reactive oxygen species metabolic process

description: Any process that modulates the frequency, rate or extent of reactive oxygen species metabolic process.


regulation of interleukin-1 production

description: Any process that modulates the frequency, rate, or extent of interleukin-1 production.


regulation of heterochromatin formation

description: Any process that modulates the frequency, rate, extent or location of heterochromatin formation.


name: positive regulation of mating-type specific transcription, DNA-templated

description: Any mating-type specific process that activates or increases the rate of cellular DNA-templated transcription.


name: negative regulation of gene expression via chromosomal CpG island methylation

description: An epigenetic gene regulation mechanism that negatively regulates gene expression by methylation of cytosine residues in chromosomal CpG islands. CpG islands are genomic regions that contain a high frequency of the CG dinucleotide associated with the transcription start site of genes.


name: regulation of inositol phosphate biosynthetic process

description: Any process that modulates the rate, frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.


name: negative regulation of triglyceride metabolic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.


name: regulation of nuclear-transcribed mRNA catabolic process, meiosis-specific transcripts

description: Any process that modulates the rate, frequency, or extent of selective degradation of meiosis-specific nuclear transcribed transcripts during vegetative growth, by a mechanism that requires determinant of selective removal (DSR) sequences in the targeted mRNAs and involves a YTH family protein.


name: positive regulation of inositol phosphate biosynthetic process

description: Any process that increases the rate, frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.


name: regulation of guanylate cyclase activity

description: Any process that modulates the frequency, rate or extent of guanylate cyclase activity.


name: regulation of phosphatidylglycerol biosynthetic process

description: Any process that modulates the frequency, rate or extent of phosphatidylglycerol biosynthetic process.


name: siRNA-mediated gene silencing by mRNA destabilization

description: An siRNA-mediated post-transcriptional gene silencing pathway in which small interfering RNAs (siRNAs) direct the cleavage of target mRNAs. Once incorporated into a RNA-induced silencing complex (RISC), an siRNA will typically direct cleavage by base pairing with perfect or near-perfect complementarity to the target mRNA.


name: regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria

description: Any process that modulates the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria.


name: regulation of tatiopterin biosynthetic process

description: Any process that modulates the frequency, rate or extent of tatiopterin biosynthetic process.


name: regulation of ethylene biosynthetic process

description: Any process that modulates the frequency, rate, or extent of an ethylene biosynthetic process.


name: negative regulation of methyl-branched fatty acid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of methyl-branched fatty acid biosynthetic process.


name: regulation of antibacterial peptide secretion

description: Any process that modulates the frequency, rate, or extent of antibacterial peptide secretion.


name: regulation of cutin biosynthetic process

description: Any process that modulates the frequency, rate or extent of cutin biosynthetic process.


name: positive regulation of purine nucleotide catabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of purine nucleotides.


name: regulation of transcription from RNA polymerase II promoter by glucose

description: Any process involving glucose that modulates the frequency, rate or extent of transcription from an RNA polymerase II promoter.


name: negative regulation of interleukin-1 alpha production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 alpha production.


name: negative regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of biosynthesis of antibacterial peptides active against Gram-positive bacteria.


name: negative regulation of carotenoid biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of carotenoid biosynthetic process.


name: negative regulation of transforming growth factor beta1 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta1.


name: regulation of transforming growth factor beta3 production

description: Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta3.


name: positive regulation of vitamin E biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of vitamin E biosynthetic process.


name: positive regulation of methane biosynthetic process from trimethylamine

description: Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from trimethylamine.


name: negative regulation of macrophage colony-stimulating factor production

description: Any process that stops, prevents or reduces the frequency, rate or extent of macrophage colony-stimulating factor production.


name: regulation of transcription by galactose

description: Any process involving galactose that modulates the frequency, rate or extent or transcription.


name: regulation of hydrogen peroxide metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving hydrogen peroxide.


name: regulation of cell wall (1->3)-beta-D-glucan biosynthetic process

description: Any process that modulates the rate, frequency, or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans, compounds composed of glucose residues linked by (1->3)-beta-D-glucosidic bonds, found in the walls of cells.


name: programmed DNA elimination by elimination of internal DNA segments

description: A programmed DNA elimination mechanism in which specific sequences, namely, internal eliminated sequences (IES) and breakage eliminated sequences (BES) are removed from the genome. This process is known to occur in ciliates.


name: negative regulation of interleukin-37 production

description: Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-37 production.


transitive RNA interference

description: An RNA interference where the silencing signal spreads along the target mRNA in a 5' or 3' direction, outside of the initial target sequence.


name: epigenetic programming in the central cell

description: The establishment of epigenetic modifications (imprints) in a plant central cell, leading to an asymmetry between the two maternal alleles and the paternal allele, and differential expression of the corresponding alleles in the developing endosperm. This can happen through heterochromatin formation or differential chromatin loop formation.


name: regulation of phosphatidylserine metabolic process

description: Any process that modulates the frequency, rate or extent of phosphatidylserine metabolic process.


regulation of aggrephagy

description: Any process that modulates the frequency, rate or extent of aggrephagy.


name: positive regulation of chemokine (C-X-C motif) ligand 2 production

description: Any process that activates or increases the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.


name: regulation of (R)-mevalonic acid biosynthetic process

description: Any process that modulates the frequency, rate or extent of (R)-mevalonic acid biosynthetic process.


name: nitrogen catabolite regulation of transcription

description: A transcription regulation process in which the presence of one nitrogen source leads to the modulation of the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other nitrogen sources.


name: regulation of DNA-templated transcription initiation

description: Any process that modulates the frequency, rate or extent of DNA-templated transcription initiation.


name: positive regulation of phospholipid metabolic process

description: Any process that activates or increases the frequency, rate or extent of phospholipid metabolic process.


name: negative regulation of triglyceride catabolic process

description: Any process that decreases the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of triglyceride.


name: regulation of ent-pimara-8(14),15-diene biosynthetic process

description: Any process that modulates the frequency, rate or extent of ent-pimara-8(14),15-diene biosynthetic process.


name: positive regulation of interleukin-21 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-21 production.


name: negative regulation of transforming growth factor beta2 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta2.


name: regulation of siRNA-mediated facultative heterochromatin formation

description: Any process that modulates the frequency, rate or extent of siRNA-dependent facultative heterochromatin formation.


name: symbiont-mediated suppression of host mRNA splicing

description: A process in which a symbiont inhibits or disrupts the splicing of host mRNA, thus interfering with normal host protein production. The host is defined as the larger of the organisms involved in a symbiotic interaction.


name: positive regulation of transcription from a mobile element promoter

description: Any process that activates or increases the frequency, rate or extent of transcription from a mobile element promoter.


name: negative regulation of interleukin-26 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-26 production.


name: positive regulation of reactive oxygen species metabolic process

description: Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process.


name: negative regulation of phosphatidylinositol biosynthetic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phosphatidylinositol.


name: positive regulation of piRNA transcription

description: Any process that increases the frequency, rate or extent of the synthesis of piRNA.


name: regulation of type II interferon production

description: Any process that modulates the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.


name: positive regulation of transcription by transcription factor localization

description: Any process that activates or increases the frequency, rate or extent of DNA-dependent transcription using a mechanism that involves the localization of a transcription factor.


regulation of interleukin-34 production

description: Any process that modulates the frequency, rate or extent of interleukin-34 production.


name: regulation of error-prone translesion synthesis

description: Any process that modulates the frequency, rate or extent of error-prone translesion synthesis.


name: siRNA-mediated facultative heterochromatin formation

description: The formation of facultative heterochromatin into a heterochromatin domain, enriched in histone H3 methylated on lysine 9 (H3K9me), by a process mediated by a small interfering RNA.


name: positive regulation of heptadecane biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of heptadecane biosynthetic process.


name: positive regulation of antimicrobial peptide biosynthetic process

description: Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide biosynthesis.


name: regulation of T cell cytokine production

description: Any process that modulates the frequency, rate, or extent of T cell cytokine production.


regulation of interleukin-5 production

description: Any process that modulates the frequency, rate, or extent of interleukin-5 production.


name: positive regulation of macromolecule biosynthetic process

description: Any process that increases the rate, frequency or extent of the chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.


name: regulation of cyclic nucleotide catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of cyclic nucleotides.


name: negative regulation of natural killer cell cytokine production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of natural killer cell cytokine production.


name: regulation of amylopectin catabolic process

description: Any process that modulates the frequency, rate or extent of amylopectin catabolic process.


name: regulation of cytochrome-c oxidase activity

description: Any process that modulates the frequency, rate or extent of cytochrome-c oxidase activity.


name: regulation of cellular catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells.


name: positive regulation of (1->3)-beta-D-glucan biosynthetic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of (1->3)-beta-D-glucans.


name: positive regulation of diacylglycerol kinase activity

description: Any process that activates or increases the frequency, rate or extent of diacylglycerol kinase activity.


name: negative regulation of chemokine (C-X-C motif) ligand 1 production

description: Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 1 production.


name: nitrogen catabolite activation of transcription

description: A transcription regulation process in which the presence of one nitrogen source leads to an increase in the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other nitrogen sources.


name: regulation of granulocyte colony-stimulating factor production

description: Any process that modulates the frequency, rate, or extent of production of granulocyte colony-stimulating factor.


tRNA destabilization

description: Any process that decreases the stability of a tRNA molecule, making it more vulnerable to degradative processes.


name: negative regulation of interferon-beta production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-beta production.


name: dosage compensation by inactivation of X chromosome

description: Compensating for the two-fold variation in X-chromosome:autosome ratios between sexes by heterochromatin formation leading to a global inactivation of all, or most of, the genes on one of the X-chromosomes in the XX sex.


name: negative regulation of mast cell cytokine production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell cytokine production.


induction by virus of host autophagy

description: Any process in which a virus activates or increases the frequency, rate or extent of autophagy in the host.


name: negative regulation of monocyte chemotactic protein-1 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of monocyte chemotactic protein-1.


name: positive regulation of tatiopterin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of tatiopterin biosynthetic process.


name: regulation of pentadecane biosynthetic process

description: Any process that modulates the frequency, rate or extent of pentadecane biosynthetic process.


name: positive regulation of antisense RNA transcription

description: Any process that increases the frequency, rate or extent of the synthesis of antisense RNA, an RNA molecule complementary in sequence to another RNA or DNA molecule, which, by binding the latter, acts to inhibit its function and/or completion of synthesis, on a template of DNA.


name: regulation of mitochondrial ATP synthesis coupled electron transport

description: Any process that modulates the frequency, rate or extent of mitochondrial ATP synthesis coupled electron transport.


name: positive regulation of glycolytic process through fructose-6-phosphate

description: Any process that activates or increases the frequency, rate or extent of glycolytic process through fructose-6-phosphate.


regulation of interleukin-15 production

description: Any process that modulates the frequency, rate, or extent of interleukin-15 production.


name: silent mating-type cassette heterochromatin formation

description: Repression of transcription at silent mating-type loci by alteration of the structure of chromatin.


name: negative regulation of bile acid metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of bile acid metabolic process.


name: negative regulation of transforming growth factor beta3 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta3.


name: regulation of RNA polymerase III activity

description: Any process that modulates the frequency, rate or extent of RNA polymerase III activity.


name: regulation of regulatory ncRNA-mediated heterochromatin formation

description: Any process that modulates the frequency, rate or extent of small non-coding RNA-mediated heterochromatin formation.


name: positive regulation of DNA-binding transcription factor activity

description: Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription.


name: positive regulation of hydrogen peroxide biosynthetic process

description: Any process that increases the rate, frequency or extent of hydrogen peroxide biosynthesis. The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA.


name: regulation of vitamin A metabolic process

description: Any process that modulates the frequency, rate or extent of vitamin A metabolic process.


regulation of lipid kinase activity

description: Any process that modulates the frequency, rate or extent of lipid kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a simple or complex lipid.


name: negative regulation of pentadecane biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of pentadecane biosynthetic process.


name: positive regulation of antimicrobial peptide secretion

description: Any process that activates or increases the frequency, rate, or extent of antimicrobial peptide secretion.


name: positive regulation of juvenile hormone catabolic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of juvenile hormone.


name: positive regulation of myeloid dendritic cell cytokine production

description: Any process that activates or increases the frequency, rate, or extent of myeloid dendritic cell cytokine production.


regulation of interleukin-11 production

description: Any process that modulates the frequency, rate, or extent of interleukin-11 production.


name: negative regulation of interleukin-34 production

description: Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-34 production.


name: regulation of pectin biosynthetic process

description: Any process that modulates the frequency, rate or extent of pectin biosynthetic process.


name: regulation of hexadecanal metabolic process

description: Any process that modulates the frequency, rate or extent of hexadecanal metabolic process.


name: positive regulation of phosphatidylglycerol biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of phosphatidylglycerol biosynthetic process.


name: negative regulation of cellular metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances.


regulation of interleukin-33 production

description: Any process that modulates the frequency, rate or extent of interleukin-33 production.


name: regulation of chemokine (C-C motif) ligand 4 production

description: Any process that modulates the frequency, rate, or extent of production of chemokine (C-C motif) ligand 4.


regulation of interleukin-37 production

description: Any process that modulates the frequency, rate or extent of interleukin-37 production.


positive regulation of aggrephagy

description: Any process that activates or increases the frequency, rate or extent of aggrephagy.


name: positive regulation of type III interferon production

description: Any process that activates or increases the frequency, rate, or extent of type III interferon production. Interferon lambda is the only member of the type III interferon found so far.


name: positive regulation of chemokine (C-C motif) ligand 1 production

description: Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 1.


name: negative regulation of reactive oxygen species metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species metabolic process.


regulation of interleukin-4 production

description: Any process that modulates the frequency, rate, or extent of interleukin-4 production.


name: negative regulation of interleukin-16 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-16 production.


name: positive regulation of pentadecane metabolic process

description: Any process that activates or increases the frequency, rate or extent of pentadecane metabolic process.


name: regulation of 4,6-pyruvylated galactose residue biosynthetic process

description: Any process that modulates the rate, frequency, or extent of 4,6-pyruvylated galactose residue biosynthetic process, the chemical reactions and pathways resulting in the formation of the pyruvylated galactose residue 4-6-O-[(R)(1-carboxyethylidine)]-Gal-beta-(1->3)-. The galactose residue is part of a larger polysaccharide chain.


name: post-transcriptional regulation of gene expression

description: Any process that modulates the frequency, rate or extent of gene expression after the production of an RNA transcript.


name: lncRNA-mediated post-transcriptional gene silencing

description: A post-transcriptional gene silencing pathway in which regulatory long noncoding RNAs (lncRNAs) elicit silencing of specific target genes, often miRNAs or mRNAs.


name: positive regulation of ergosterol biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of ergosterol.


name: regulation of phospholipid metabolic process

description: Any process that modulates the frequency, rate or extent of phospholipid metabolic process.


name: positive regulation of MHC class I biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class I.


name: regulation of cellular organofluorine metabolic process

description: Any process that modulates the rate, frequency or extent of the chemical reactions and pathways involving organofluorine compounds, as carried out by individual cells.


name: regulation of phospholipid catabolic process

description: Any process that modulates the rate, frequency, or extent of phospholipid catabolism, the chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester.


name: negative regulation of hydrogen peroxide catabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of hydrogen peroxide catabolic process.


name: siRNA-mediated long-distance post-transcriptional gene silencing

description: An siRNA-mediated posttranscriptional gene silencing pathway in which small interfering RNAs (siRNAs) direct the cleavage of target mRNAs, and in which the silencing signal originates in one tissue and occurs in a different tissue.


name: negative regulation of nitric-oxide synthase biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of a nitric-oxide synthase enzyme.


negative regulation of kinase activity

description: Any process that stops, prevents, or reduces the frequency, rate or extent of kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.


name: negative regulation of cardiolipin metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of cardiolipin metabolic process.


name: positive regulation of 3'-UTR-mediated mRNA stabilization

description: Any process that activates or increases the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.


name: positive regulation of bile acid metabolic process

description: Any process that activates or increases the frequency, rate or extent of bile acid metabolic process.


name: regulation of pyrimidine nucleotide biosynthetic process

description: Any process that modulates the frequency, rate or extent of pyrimidine nucleotide biosynthetic process.


regulation of siRNA processing

description: Any process that modulates the frequency, rate or extent of siRNA processing.


name: negative regulation of UDP-glucose catabolic process

description: Any process that decreases the rate, frequency or extent of UDP-glucose catabolism. UDP-glucose catabolic processes are the chemical reactions and pathways resulting in the breakdown of UDP-glucose, uridinediphosphoglucose, a substance composed of glucose in glycosidic linkage with uridine diphosphate.


name: positive regulation of interleukin-7 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-7 production.


name: negative regulation of interleukin-20 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-20 production.


name: negative regulation of interleukin-24 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-24 production.


regulation of xenophagy

description: Any process that modulates the frequency, rate or extent of xenophagy.


name: negative regulation of glycogen metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving glycogen.


name: regulation of phosphatidic acid biosynthetic process

description: Any process that modulates the frequency, rate or extent of phosphatidic acid biosynthetic process.


programmed DNA elimination

description: A process in which genomic fragments or entire chromosomes are eliminated from somatic cells or from micronuclei of ciliates. This process occurs in the developing macronucleus (anlage) of a ciliate, as well as in other species, including vertebrates and is an irreversible mechanism of gene silencing.


name: positive regulation of post-transcriptional gene silencing by RNA

description: Any process that activates or increases the frequency, rate or extent of post-transcriptional gene silencing by RNA.


name: negative regulation of interleukin-2 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-2 production.


name: positive regulation of cellular respiration

description: Any process that activates or increases the frequency, rate or extent of cellular respiration.


name: negative regulation of sarcinapterin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of sarcinapterin biosynthetic process.


name: regulation of MHC class II biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of MHC class II.


name: positive regulation of hexokinase activity

description: Any process that activates or increases the frequency, rate or extent of hexokinase activity.


regulation of phosphorylation

description: Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule.


name: positive regulation of fractalkine production

description: Any process that activates or increases the frequency, rate, or extent of fractalkine production.


name: regulation of sarcinapterin biosynthetic process

description: Any process that modulates the frequency, rate or extent of sarcinapterin biosynthetic process.


name: negative regulation of glycogen catabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of glycogen.


name: negative regulation of cytochrome-c oxidase activity

description: Any process that stops, prevents or reduces the frequency, rate or extent of cytochrome-c oxidase activity.


name: regulation of DNA-templated transcription elongation

description: Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.


name: positive regulation of interleukin-13 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.


name: regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process

description: Any process that modulates the frequency, rate or extent of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate catabolic process.


name: positive regulation of amylopectin metabolic process

description: Any process that activates or increases the frequency, rate or extent of amylopectin metabolic process.


name: negative regulation of transforming growth factor beta production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of transforming growth factor-beta.


name: regulation of alkaline phosphatase activity

description: Any process that modulates the frequency, rate or extent of alkaline phosphatase activity, the catalysis of the reaction: an orthophosphoric monoester + H2O = an alcohol + phosphate, with an alkaline pH optimum.


name: negative regulation of cellular organofluorine metabolic process

description: Any process that decreases the rate, frequency or extent of the chemical reactions and pathways involving organofluorine compounds, as carried out by individual cells.


name: negative regulation of triglyceride biosynthetic process

description: Any process that decreases the rate, frequency, or extent of triglyceride biosynthesis. Triglyceride biosynthesis is the collection of chemical reactions and pathways resulting in the formation of triglyceride, any triester of glycerol.


name: negative regulation of antifungal peptide biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of antifungal peptide biosynthesis.


regulation of toluene catabolic process

description: Any process that modulates the frequency, rate or extent of toluene catabolic process.


name: regulation of antimicrobial peptide secretion

description: Any process that modulates the frequency, rate, or extent of antimicrobial peptide secretion.


negative regulation of siRNA processing

description: Any process that stops, prevents or reduces the frequency, rate or extent of siRNA processing.


name: negative regulation of granzyme A production

description: Any process that stops, prevents or reduces the frequency, rate or extent of granzyme A production.


name: positive regulation of interleukin-17 production

description: Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.


name: regulation of antimicrobial peptide biosynthetic process

description: Any process that modulates the frequency, rate, or extent of antimicrobial peptide biosynthesis.


name: negative regulation of methane biosynthetic process from trimethylamine

description: Any process that stops, prevents or reduces the frequency, rate or extent of methane biosynthetic process from trimethylamine.


name: regulation of tridecane biosynthetic process

description: Any process that modulates the frequency, rate or extent of tridecane biosynthetic process.


name: negative regulation of beta 2 integrin biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of beta 2 integrins.


name: negative regulation of diacylglycerol kinase activity

description: Any process that stops, prevents or reduces the frequency, rate or extent of diacylglycerol kinase activity.


negative regulation of autophagy

description: Any process that stops, prevents, or reduces the frequency, rate or extent of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.


name: regulation of vascular endothelial growth factor production

description: Any process that modulates the frequency, rate, or extent of production of vascular endothelial growth factor.


name: regulation of juvenile hormone metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving juvenile hormone.


name: regulation of transforming growth factor beta production

description: Any process that modulates the frequency, rate, or extent of production of transforming growth factor-beta.


name: negative regulation of reductive pentose-phosphate cycle

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the reductive pentose-phosphate cycle.


name: negative regulation of tumor necrosis factor superfamily cytokine production

description: Any process that stops, prevents or reduces the frequency, rate or extent of tumor necrosis factor superfamily cytokine production.


name: regulation of phospholipid biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phospholipids.


name: negative regulation of 3'-UTR-mediated mRNA stabilization

description: Any process that stops, prevents or reduces the frequency, rate or extent of 3'-UTR-mediated mRNA stabilization.


name: negative regulation of interleukin-3 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-3 production.


name: negative regulation of cutin biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of cutin biosynthetic process.


name: positive regulation of phospholipid catabolic process

description: Any process that increases the rate, frequency, or extent of phospholipid catabolism, the chemical reactions and pathways resulting in the breakdown of phospholipids, any lipid containing phosphoric acid as a mono- or diester.


name: negative regulation of phosphorus metabolic process

description: Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving phosphorus or compounds containing phosphorus.


name: negative regulation of post-transcriptional gene silencing by regulatory ncRNA

description: Any process that stops, prevents or reduces the frequency, rate or extent of post-transcriptional gene silencing by RNA.


name: positive regulation of isoprene metabolic process

description: Any process that activates or increases the frequency, rate or extent of isoprene metabolic process.


name: positive regulation of vascular endothelial growth factor production

description: Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.


regulation of interleukin-18 production

description: Any process that modulates the frequency, rate, or extent of interleukin-18 production.


name: negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity

description: Any process that stops, prevents or reduces the frequency, rate or extent of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity.


name: positive regulation of methane biosynthetic process from dimethyl sulfide

description: Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from dimethyl sulfide.


name: regulation of phosphate metabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving phosphates.


name: positive regulation of interleukin-24 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-24 production.


name: positive regulation of regulation of ascospore wall (1->3)-beta-D-glucan biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of ascospore wall (1->3)-beta-D-glucan biosynthetic process.


name: regulation of siRNA-independent facultative heterochromatin formation

description: Any process that modulates the frequency, rate or extent of siRNA-independent facultative heterochromatin assembly.


name: negative regulation of connective tissue growth factor production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of connective tissue growth factor production.


name: negative regulation of glycolytic fermentation to ethanol

description: Any process that stops, prevents or reduces the frequency, rate or extent of glucose catabolic process to ethanol.


name: negative regulation of reactive oxygen species biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of reactive oxygen species biosynthetic process.


regulation of cellular respiration

description: Any process that modulates the frequency, rate or extent of cellular respiration, the enzymatic release of energy from organic compounds.


name: negative regulation of mitochondrial ATP synthesis coupled electron transport

description: Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial ATP synthesis coupled electron transport.


epigenetic programming in the endosperm

description: The global programming of epigenetic modifications following binucleate central cell fertilization. This involves DNA methylation at the silent allele. In the endosperm, maternal genomes are hypomethylated compared with the paternal genome.


name: gene silencing by piRNA-directed DNA methylation

description: A small RNA-based gene silencing process in which Piwi-associated RNAs (piRNAs) guide de novo DNA methylation. This results in a heterochromatin assembly, a chromatin conformation that is refractory to transcription.


name: nuclear-transcribed mRNA catabolic process, RNase MRP-dependent

description: A minor MRP-dependent nuclear-transcribed mRNA degradation pathway that begins with an endonucleolytic cleavage to generate unprotected ends.


name: regulation of rDNA heterochromatin formation

description: Any process that modulates the rate, frequency, or extent of rDNA heterochromatin formation.


name: regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway

description: Any process that modulates the frequency, rate or extent of isopentenyl diphosphate biosynthetic process, mevalonate pathway.


name: polyuridylation-dependent mRNA catabolic process

description: The chemical reactions and pathways resulting in the breakdown of a messenger RNA (mRNA) molecule, initiated by the enzymatic addition of a sequence of uridylyl residues (polyuridylation) at the 3' end of the target mRNA.


name: regulation of starch biosynthetic process

description: An process which modulate the frequency, rate or extent of starch biosynthesis, the chemical reactions and pathways resulting in the formation of starch.


name: regulation of transcription elongation by RNA polymerase I

description: Any process that modulates the frequency, rate or extent of transcription elongation from RNA polymerase I promoter.


name: regulation of sterigmatocystin biosynthetic process

description: Any process that modulates the rate, frequency, or extent of sterigmatocystin biosynthesis. Sterigmatocystin biosynthetic processes are the chemical reactions and pathways resulting in the formation of sterigmatocystin, a carcinogenic mycotoxin produced in high yields by strains of the common molds.


name: negative regulation of inositol trisphosphate biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of inositol trisphosphate.


name: regulation of phosphatidylcholine catabolic process

description: Any process that modulates the rate, frequency or extent of phosphatidylcholine catabolism. Phosphatidylcholine catabolic processes are the chemical reactions and pathways resulting in the breakdown of phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline.


name: regulation of glucan biosynthetic process

description: Any process that modulates the rate, frequency, or extent of glucan biosynthesis. Glucan biosynthetic processes are the chemical reactions and pathways resulting in the formation of glucans, polysaccharides consisting only of glucose residues.


regulation of oxidative phosphorylation

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis.


name: positive regulation of androgen receptor activity

description: Any process that activates or increases the frequency, rate or extent of androgen receptor activity.


regulation of tRNA stability

description: Any process that modulates the propensity of transfer RNA (tRNA) molecules to degradation. Includes processes that both stabilize and destabilize tRNAs.


name: positive regulation of chemokine (C-C motif) ligand 5 production

description: Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 5.


name: regulation of RNA polymerase II transcription preinitiation complex assembly

description: Any process that modulates the frequency, rate or extent of RNA polymerase II transcriptional preinitiation complex assembly.


name: positive regulation of transcription by RNA polymerase I

description: Any process that activates or increases the frequency, rate or extent of transcription mediated by RNA polymerase I.


name: positive regulation of telomerase RNA reverse transcriptase activity

description: Any process that activates or increases the frequency, rate or extent of telomerase RNA reverse transcriptase activity.


positive regulation of phosphorylation

description: Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.


name: regulation of purine nucleotide catabolic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of purine nucleotides.


name: positive regulation of fumagillin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of fumagillin biosynthetic process.


name: positive regulation of plant-type cell wall cellulose biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of plant-type cell wall cellulose biosynthetic process.


name: positive regulation of autophagy in response to ER overload

category: biolink:Pathway biolink:OntologyClass biolink:BiologicalProcess biolink:Occurrent biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing biolink:PhysicalEssenceOrOccurrent

description: The process in which the accumulation of misfolded proteins in the endoplasmic reticulum triggers a response that positively regulates autophagy.


name: regulation of T-helper 2 cell cytokine production

description: Any process that modulates the frequency, rate or extent of T-helper 2 cell cytokine production.


name: regulation of transcription initiation by RNA polymerase I

description: Any process that modulates the frequency, rate or extent of transcription initiation from RNA polymerase I promoter.


name: positive regulation of type II interferon production

description: Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.


name: regulation of fructose 1,6-bisphosphate metabolic process

description: Any process that modulates the rate, frequency or extent of fructose 1,6-bisphosphate metabolism. Fructose 1,6-bisphosphate metabolism is the chemical reactions and pathways involving fructose 1,6-bisphosphate, also known as FBP. The D enantiomer is a metabolic intermediate in glycolysis and gluconeogenesis.


name: negative regulation of phosphatase activity

description: Any process that decreases the rate or frequency of phosphatase activity. Phosphatases catalyze the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.


name: regulation of removal of superoxide radicals

description: Any process that modulates the frequency, rate or extent of removal of superoxide radicals.


regulation of cytokine production

description: Any process that modulates the frequency, rate, or extent of production of a cytokine.


name: negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization

description: Any process that stops, prevents or reduces the frequency, rate or extent of parkin-mediated mitophagy in response to mitochondrial depolarization.


name: positive regulation of interleukin-8 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.


name: regulation of telomerase RNA reverse transcriptase activity

description: Any process that modulates the frequency, rate or extent of telomerase RNA reverse transcriptase activity.


name: positive regulation of cutin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of cutin biosynthetic process.


name: negative regulation of chemokine (C-X-C motif) ligand 2 production

description: Any process that stops, prevents or reduces the frequency, rate or extent of chemokine (C-X-C motif) ligand 2 production.


name: positive regulation of beta 2 integrin biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of beta 2 integrins.


maternal mRNA clearance

description: The chemical reactions and pathways resulting in the clearance of maternal mRNA transcripts from the zygote as part of the maternal-to-zygote transition in gene expression.


positive regulation of TRAIL production

description: Any process that activates or increases the frequency, rate, or extent of TRAIL production.


name: positive regulation of natural killer cell cytokine production

description: Any process that activates or increases the frequency, rate, or extent of natural killer cell cytokine production.


regulation of DNA biosynthetic process

description: Any process that modulates the frequency, rate or extent of DNA biosynthetic process.


name: positive regulation of methane biosynthetic process from dimethylamine

description: Any process that activates or increases the frequency, rate or extent of methane biosynthetic process from dimethylamine.


positive regulation of autophagy

description: Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.


name: negative regulation of CREB transcription factor activity

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor CREB.


name: positive regulation of hexadecanal biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of hexadecanal biosynthetic process.


name: negative regulation of T-helper 2 cell cytokine production

description: Any process that stops, prevents or reduces the frequency, rate or extent of T-helper 2 cell cytokine production.


name: regulation of mitochondrial gene expression

description: Any process that modulates the frequency, rate or extent of mitochondrial gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).


name: regulation of transcriptional start site selection at RNA polymerase II promoter

description: Any process that modulates the rate, frequency or extent of a process involved in the selection of the specific location within the template strand of an RNA polymerase II promoter for hybridization of the cognate ribonucleotides and formation of first phosphodiester bond within the nascent transcript.


name: negative regulation of chemokine (C-C motif) ligand 6 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of chemokine (C-C motif) ligand 6 (CCL6).


name: regulation of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process

description: Any process that modulates the frequency, rate or extent of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process.


name: positive regulation of nucleotide biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nucleotides.


name: regulation of pericentric heterochromatin formation

description: Any process that modulates the frequency, rate or extent of heterochromatin formation at the centromere. Chromatin silencing at the centromere is the repression of transcription of centromeric DNA by altering the structure of chromatin.


name: regulation of B cell cytokine production

description: Any process that modulates the frequency, rate, or extent of B cell cytokine production.


name: regulation of octadecene metabolic process

description: Any process that modulates the frequency, rate or extent of octadecene metabolic process.


name: positive regulation of interleukin-9 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-9 production.


name: regulation of superoxide anion generation

description: Any process that modulates the frequency, rate or extent of enzymatic generation of superoxide by a cell.


regulation of miRNA processing

description: Any process that modulates the frequency, rate or extent of microRNA processing.


name: regulation of macrophage inflammatory protein-1 gamma production

description: Any process that modulates the frequency, rate, or extent of production of macrophage inflammatory protein-1 gamma.


name: positive regulation of juvenile hormone biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of juvenile hormone.


name: negative regulation of juvenile hormone metabolic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving juvenile hormone.


name: positive regulation of phosphatidylinositol biosynthetic process

description: Any process that increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of phosphatidylinositol.


name: positive regulation of interleukin-2 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.


name: regulation of macromolecule biosynthetic process

description: Any process that modulates the rate, frequency or extent of the chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass.


name: negative regulation of ATP metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of ATP metabolic process.


regulation of RNA stability

description: Any process that modulates the propensity of RNA molecules to degradation. Includes processes that both stabilize and destabilize RNAs.


negative regulation of photosynthesis

description: Any process that stops, prevents or reduces the frequency, rate or extent of photosynthesis.


name: regulation of octadecene biosynthetic process

description: Any process that modulates the frequency, rate or extent of octadecene biosynthetic process.


name: negative regulation of ATP biosynthetic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process.


name: negative regulation of inositol phosphate biosynthetic process

description: Any process that decreases the rate, frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached.


name: positive regulation of myeloid leukocyte cytokine production involved in immune response

description: Any process that modulates the rate, frequency, or extent of the production of a cytokine that contributes to the immune response.


name: regulation of aflatoxin biosynthetic process

description: Any process that modulates the frequency, rate or extent of aflatoxin biosynthetic process.


name: regulation of hyaluronan biosynthetic process

description: Any process that modulates the frequency, rate or extent of hyaluronan biosynthetic process.


name: positive regulation of transcription by glucose

description: Any process involving glucose that activates or increases the rate of transcription.


name: regulation of beta 2 integrin biosynthetic process

description: Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of beta 2 integrins.


name: negative regulation of interleukin-6 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.


name: positive regulation of quinolinate biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of quinolinate biosynthetic process.


name: regulation of heptadecane metabolic process

description: Any process that modulates the frequency, rate or extent of heptadecane metabolic process.


name: regulation of methane biosynthetic process from carbon monoxide

description: Any process that modulates the frequency, rate or extent of methane biosynthetic process from carbon monoxide.


name: regulation of phytol biosynthetic process

description: Any process that modulates the frequency, rate or extent of phytol biosynthetic process.


name: regulation of post-transcriptional gene silencing

description: Any process that modulates the frequency, rate or extent of the inactivation of gene expression by a posttranscriptional mechanism.


name: negative regulation of mitochondrial electron transport, NADH to ubiquinone

description: Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone.


name: carbon catabolite regulation of transcription from RNA polymerase II promoter

description: A transcription regulation process in which the presence of one carbon source leads to the modulation of the frequency, rate, or extent of transcription, from an RNA polymerase II promoter, of specific genes involved in the metabolism of other carbon sources.


name: positive regulation of chemokine (C-C motif) ligand 4 production

description: Any process that activates or increases the frequency, rate, or extent of production of chemokine (C-C motif) ligand 4.


name: positive regulation of granulocyte colony-stimulating factor production

description: Any process that activates or increases the frequency, rate, or extent of production of granulocyte colony-stimulating factor.


regulation of interleukin-3 production

description: Any process that modulates the frequency, rate, or extent of interleukin-3 production.


name: negative regulation of interleukin-32 production

description: Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-32 production.


name: regulation of receptor catabolic process

description: Any process that modulates the frequency, rate or extent of receptor catabolic process.


name: negative regulation of integrin biosynthetic process

description: Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of integrins.


circadian regulation of gene expression

description: Any process that modulates the frequency, rate or extent of gene expression such that an expression pattern recurs with a regularity of approximately 24 hours.


name: positive regulation of interleukin-5 production

description: Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.


name: negative regulation of interleukin-5 production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-5 production.


name: positive regulation of T cell cytokine production

description: Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.


name: regulation of antifungal peptide production

description: Any process that modulates the frequency, rate, or extent of antifungal peptide production.


regulation of phosphorus utilization

description: Any process that modulates the frequency, rate or extent of phosphorus utilization.


name: positive regulation of interleukin-37 production

description: Any process that activates or increases the frequency, rate or extent of interleukin-37 production.


name: regulation of phosphatidylinositol dephosphorylation

description: Any process that modulates the frequency, rate or extent of the chemical reaction involving the removal of one or more phosphate groups from a phosphatidylinositol.


regulation of granzyme A production

description: Any process that modulates the frequency, rate or extent of granzyme A production.


post-transcriptional gene silencing

description: The inactivation of gene expression that occurs after transcription.


name: positive regulation of methyl-branched fatty acid biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of methyl-branched fatty acid biosynthetic process.


name: positive regulation of tumor necrosis factor (ligand) superfamily member 11 production

description: Any process that activates or increases the frequency, rate or extent of tumor necrosis factor (ligand) superfamily member 11 production.


name: positive regulation of ethylene biosynthetic process

description: Any process that activates or increases the frequency, rate or extent of an ethylene biosynthetic process.


name: regulation of ribosomal protein gene transcription by RNA polymerase II

description: Any process that modulates the frequency, rate or extent of the synthesis of RNA from ribosomal protein genes mediated by RNA polymerase II.


name: regulation of glial cell-derived neurotrophic factor production

description: Any process that modulates the frequency, rate or extent of glial cell-derived neurotrophic factor production.


name: negative regulation of granzyme B production

description: Any process that stops, prevents, or reduces the frequency, rate, or extent of production of granzyme B.


name: positive regulation of NAD+ kinase activity

description: Any process that activates or increases the frequency, rate or extent of NAD kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to an NAD molecule.


name: negative regulation of oxygen metabolic process

description: Any process that stops, prevents or reduces the frequency, rate or extent of oxygen metabolic process.